The secondary offering adds 29M net shares to the float, creating near-term overhang. The company's $48M repurchase signals management's view that the stock is undervalued at $8.02, but the cash outlay reduces financial flexibility. Monitor for any subsequent insider selling after the lock-up expires (75 days from May 12). The offering was fully subscribed and closed, so the immediate overhang is cleared.
Price Chart
Executive Summary
LifeStance Health disclosed a secondary public offering of 35,000,000 shares of common stock by selling stockholders (TPG, Summit Partners, and director entities) at $8.15 per share, with the company concurrently repurchasing 6,000,000 shares at $8.02 per share. The company received no proceeds from the offering, which closed on May 12, 2026. The repurchase partially offsets dilution but represents a capital outlay for the company.
Key Facts
- Secondary offering of 35,000,000 shares by selling stockholders at $8.15 per share, raising approximately $285.25 million in gross proceeds for selling stockholders.
- Company repurchased 6,000,000 shares from the underwriter at $8.02 per share, costing approximately $48.12 million.
- Company received no proceeds from the offering.
- TPG VIII Lynnwood Holdings Aggregation, L.P. sold 28,281,943 shares (including 4,848,333 repurchased by the company).
- Summit Partners entities sold a combined 5,899,661 shares (including 1,011,370 repurchased by the company).
- Director selling entities (Vitthal LLC, Shama LLC, Eric Shuey Gift Trust) sold a combined 818,396 shares (including 140,297 repurchased by the company).
- Underwriter J.P. Morgan Securities LLC received no compensation for the repurchased shares.
- Standard 75-day lock-up agreements were entered into with certain equityholders, officers, and directors.
- Offering closed on May 12, 2026.
Financial Impact
Selling stockholders received approximately $285.25 million in gross proceeds. Company spent approximately $48.12 million to repurchase 6,000,000 shares, partially offsetting dilution. Net dilution to public float: 29,000,000 new shares (approximately 10-15% of pre-offering shares outstanding, based on market cap of $3.0B and offering price of $8.15 implying ~368M shares pre-offering).
Risk Factors
- Dilution of approximately 8-10% to existing shareholders from the 29M net new shares in the public float.
- Cash outflow of ~$48M for the repurchase reduces balance sheet flexibility.
- Insider selling by major shareholders (TPG, Summit) may signal lack of confidence in near-term valuation.
- Potential for additional secondary offerings if remaining lock-up shares are sold after the restricted period.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-219669 |
| Document: d107883d8k.htm | 0001193125-26-219669 |
| Document: d107883dex51.htm | 0001193125-26-219669 |
| Document: 0001193125-26-219669-index-headers.html | 0001193125-26-219669 |
| Document: 0001193125-26-219669-index.html | 0001193125-26-219669 |
| Document: 0001193125-26-219669.txt | 0001193125-26-219669 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | Court Ruling | $12.33 $12.56 | ▲ +1.87% | ▲ +3.05% | $13.06 (+5.92%) |
Oct 16, 2026 9d ago | 8-K | $11.77 $12.22 | ▲ +3.82% | ▲ +3.49% | $13.06 (+10.96%) |
Oct 15, 2026 11d ago | Press Release | $11.74 | awaiting T+1 | — | $13.06 (+11.24%) |
Oct 5, 2026 21d ago | SC 13G/A | $12.22 $12.12 | ▼ −0.82% | ▼ −1.37% | $13.06 (+6.87%) |
Sep 22, 2026 4w ago | Institutional Cluster | $12.55 $12.08 | ▼ −3.75% | ▼ −3.02% | $13.06 (+4.06%) |
Sep 11, 2026 6w ago | 8-K | $13.38 $13.06 | ▲ +2.39% | ▲ +1.93% | $13.06 (+2.39%) |
Aug 18, 2026 9w ago | Insider Cluster | $12.83 $12.65 | ▲ +1.40% | ▲ +0.56% | $13.06 (−1.79%) |
Aug 14, 2026 10w ago | Insider Cluster | $12.55 $12.36 | ▲ +1.51% | ▲ +0.84% | $13.06 (−4.06%) |
Aug 14, 2026 10w ago | 144 | $12.42 $12.55 | ▲ +1.05% | ▲ +1.52% | $13.06 (+5.15%) |
Aug 13, 2026 10w ago | Insider Cluster | $12.42 $12.55 | ▼ −1.05% | ▼ −1.52% | $13.06 (−5.15%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers